A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes by John H. Alexander
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

John H. Alexander

A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes

John H. Alexander

34 pages missing pub info (editions)

Powered by AI (Beta)
Loading...

Community Reviews

Loading...

Content Warnings

Loading...